Name | Year | Description | Reference | Functional |
---|---|---|---|---|
Timiner | 2017 | NGS data mining pipeline for cancer immunology and immunotherapy | YES | |
TIP | 2018 | A Web Server for Resolving Tumor Immunophenotype Profiling | YES | |
TSNAdb | 2018 | A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis | YES | |
ImmuCellAI | 2020 | A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy | YES | |
Checkpoint therapeutic target database (CKTTD) | 2020 | he first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy | YES | |
CanImmunother | 2021 | a manually curated database for identification of cancer immunotherapies associating with biomarkers, targets, and clinical effects | YES | |
CancerImmunityQTL | 2021 | a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer | YES | |
NEPdb | 2021 | A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy | YES | |
Cancer Antigen Atlas (caAtlas) | 2021 | Comprehensive resource for the selection and prioritization of peptides for immunogenicity testing and cancer immunotherapy development | YES | |
CIDR | - | Cellular Immunotherapy Data Resource | YES | |
OvirusTdb | 2020 | Oncolytic viruses for the advancement of therapeutics in cancer | YES | |
Cancer Antigenic Peptide Database | - | Cancer Antigenic Peptide Database | YES | |
AFND | 2020 | Knowledgebase of frequency data (alleles, genes, haplotypes and genotypes) | YES | |
CancerTope | 2016 | Genome-based personalized immunotherapy agaist cancer | YES | |
VLCvirus | 2021 | In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses | YES | |
pVACtools | 2020 | A toolkit for tumor neoantigen characterization | YES | |
pVACSeq | 2016 | In silico approach to identifying tumor neoantigens to identify checkpoint blockade inhibition | YES | |
MuPeXI | 2017 | Tumor-specific peptides and assess their potential to be neo-epitopes used for personalized cancer immunotherapy | YES | |
HLA-Arena | 2020 | Analysis of Peptide-HLA Complexes for Cancer Immunotherapy | YES |
ImmCancer: This website is maintained and developed at Raghava's Lab